Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors
NCT05142371 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2025-05-30
Summary
This clinical trial examines a telehealth exercise intervention in improving physical function and frailty in multiple myeloma survivors. The exercise program uses a telehealth platform (delivered by smart phones, tablets, or computers) to view pre-recorded exercise videos on coordination, posture, stretching, balance, and resistance/aerobic (cardio) training. Frailty includes being underweight, slow walking speed, exhaustion, low physical activity, and weakness. Participating in an exercise program may help improve patient's physical function and strength.
Conditions
- Plasma Cell Myeloma
Interventions
- OTHER
-
Best Practice
Continue current activities of daily living
- OTHER
-
Exercise Intervention
Participate in exercise intervention
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
- OTHER
-
Questionnaire Administration
Complete questionnaires
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Kyuwan Lee · City of Hope Comprehensive Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-06
- Primary Completion
- 2025-03-28
- Completion
- 2025-03-28
Countries
- United States
Study Locations
More Related Trials
-
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors
NCT05257785 ·Status: RECRUITING ·Phase: NA
-
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
NCT01793051 ·Status: COMPLETED ·Phase: PHASE2
-
The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial
NCT06228794 ·Status: RECRUITING
-
Examination of Trends in Multiple Myeloma Trial Patient Experiences
NCT05860179 ·Status: NOT_YET_RECRUITING
-
Inflammatory Cytokines in Symptom Production in Multiple Myeloma
NCT00688168 ·Status: COMPLETED
-
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
NCT07225738 ·Status: RECRUITING
-
Enhancing Cancer Survivorship With Pickleball
NCT06048822 ·Status: COMPLETED ·Phase: NA
-
Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma
NCT00942422 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients
NCT01269203 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treating Cancer-Related Fatigue Through Systematic Light Exposure (Light for Fatigue Study)
NCT03119363 ·Status: COMPLETED ·Phase: NA
-
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
NCT00541164 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prevention of Treatment Induced Neuropathy in Multiple Myeloma
NCT01283997 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
NCT00099047 ·Status: COMPLETED ·Phase: PHASE2
-
Intermittent Fasting and CLL/SLL
NCT04626843 ·Status: COMPLETED ·Phase: PHASE1
-
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
NCT00809575 ·Status: UNKNOWN
-
CC-4047 in Treating Patients With Myelofibrosis
NCT00669578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
NCT06055894 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma
NCT00503763 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
NCT06245941 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma
NCT00113841 ·Status: COMPLETED ·Phase: NA
-
Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire
NCT05817331 ·Status: COMPLETED
-
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
NCT00002850 ·Status: COMPLETED ·Phase: PHASE3
-
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
NCT04727294 ·Status: UNKNOWN
-
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
NCT00296205 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
NCT00242827 ·Status: TERMINATED ·Phase: PHASE2